You are here » Home » Companies » Company Overview » Biocon Ltd

Biocon Ltd.

BSE: 532523	Sector: Health care
NSE: BIOCON	ISIN Code: INE376G01013

BSE 00:00 | 02 Dec

283.70

-1.80
(-0.63%)

OPEN

284.05

HIGH

285.25

LOW

282.00

NSE 00:00 | 02 Dec

283.55

-2.00
(-0.70%)

OPEN

285.50

HIGH

285.55

LOW

282.00

Add to Watchlist | Add to Portfolio

OPEN	284.05
PREVIOUS CLOSE	285.50
VOLUME	42724
52-Week high	410.50
52-Week low	258.30
P/E	207.08
Mkt Cap.(Rs cr)	34,061
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

OPEN	284.05
CLOSE	285.50
VOLUME	42724
52-Week high	410.50
52-Week low	258.30
P/E	207.08
Mkt Cap.(Rs cr)	34,061
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

Biocon Ltd. (BIOCON) - Latest News & Headlines

Stocks to Watch: Zomato, SBI, Adani Group, Britannia, ONGC, Gland Pharma

8.05 am | 30 Nov 2022 | Business Standard

Stocks to Watch Today: According to reports, Zomato is likely to witness a block deal on Wednesday.
China-Plus-One strategy: Indian API firms start to reap benefits

12.03 am | 28 Nov 2022 | Business Standard

Rising Chinese labour costs, geopolitics, pandemic-stricken uncertainties have forced global players to derisk
Trying to lock in vendors who don't want to buy from China: Biocon CEO & MD

10.20 pm | 15 Nov 2022 | Business Standard

Siddharth Mittal, CEO & MD, Biocon, elaborates on his plans to grow this business further
Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%

10.13 pm | 14 Nov 2022 | Business Standard

Biocon's core Ebitda came in at Rs 816 crore, up 34 per cent
Biocon falls 12% in 5 days on one major deficiency alert for API unit

11.38 am | 12 Oct 2022 | Business Standard

The pharma company said it will respond to the European medical regulator with appropriate corrective and preventive actions within the stipulated tim...
Gautam Adani earned Rs 1,612 crore a day in 2021: Hurun India

2.58 pm | 21 Sep 2022 | Business Standard

Adani was far ahead of Reliance Industries' chairman Mukesh Ambani (Mukesh Ambani & family), whose wealth rose 11 per cent in the last one year
Syngene trades weak after nearly 6% equity changes hands via block deals

10.31 am | 6 Sep 2022 | Business Standard

At 09:15 am; around 22.68 million equity shares representing 5.65 per cent of the total equity of Syngene changed hands on the BSE, the exchange data ...
Biocon sheds 4%, hits 52-week low as US FDA issues form 483 for 3 sites

9.51 am | 1 Sep 2022 | Business Standard

The US health regulator has issued Form 483s with 11 observations each for two sites in Bengaluru and six observations for a plant in Malaysia site.
We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD

12.46 pm | 2 Aug 2022 | Business Standard

In an interview, Arun Chandravarkar explains why a company must continue investing in R&D despite the impact on short-term Ebitda
Stocks to Watch Today: Adani Power, Biocon, Tata Steel, NTPC, PSU Banks

7.31 am | 6 Jul 2022 | Business Standard

Stocks to Watch Today: Among airline shares, SpiceJet has reported seven aircraft related incidents in the last two months; while IndiGo said has hire...
Delhi HC rejects CBI plea for custody of four accused in Biocon case

2.14 am | 6 Jul 2022 | Press Trust of India

The high court, however, directed the jail superintendent to hand over the custody of associate vice president of Biocon Biologics L Praveen Kumar
Biocon Biologics bribery case: CBI moves HC challenging lower court verdict

7.55 pm | 28 Jun 2022 | Press Trust of India

The Delhi High Court has issued notices to the parties concerned and will hear the case on July 2
Zomato, Dish TV, Biocon: Trading strategies for buzzing stocks of the day

12.45 pm | 27 Jun 2022 | Business Standard

Shares of Zomato face stiff resistance at Rs 78, while the downside support stays at Rs 60
Biocon slips 4% despite arm denying bribery charges

11.07 am | 22 Jun 2022 | Business Standard

At 10:26 AM, the stock of Biocon was down 3 per cent at Rs 316.10, as compared to 1 per cent decline in the S&P BSE Sensex
Biocon hits over two-year low; slips 18% in six weeks post weak Q4 results

11.55 am | 8 Jun 2022 | Business Standard

In the past one year, the stock has slipped 22 per cent, as against a 39 per cent rally in the S&P BSE Sensex.